What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Search narrowed by
Safety warnings
|
Blood & Tissue
|
02/08/2024
The Federal Office for Safety in Health Care (BASG) has been informed by the French authorities that a confirmed human case of chikungunya has been recorded in France. The two possible infection sites are in Paris and in the neighboring town of Gennevillier (Département Hauts-de-Seine), both in the Ile-de-France region.
02/08/2024
Dem Bundesamt für Sicherheit im Gesundheitswesen (BASG) wurde von der französischen Behörde mitgeteilt, dass ein bestätigter humaner Chikungunya-Fall in Frankreich verzeichnet wurde. Die beiden möglichen Infektionsorte liegen in Paris und in der Nachbarstadt Gennevillier (Département Hauts-de-Seine), beide in der Region Ile-de-France.
Referenced at:
Buprenorphine (all formulations except implants) New
PSUR-outcome
|
31/07/2024
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Teriflunomide New
PSUR-outcome
|
31/07/2024
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Leflunomide New
PSUR-outcome
|
29/07/2024
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Safety warnings
|
Blood & Tissue
|
29/07/2024
The Federal Office for Safety in Health Care (BASG) has been informed by the French authorities that a human WNV infection has been recorded in France, in the Var department of the Provence Alpes Côte d'Azur region.
Levofloxacin (i.v. and oral use) New
PSUR-outcome
|
23/07/2024
Further information and amendments to the product information can be found on the EMA website.
Baclofen (oral, for muscle spasticity indication) New
PSUR-outcome
|
17/07/2024
Further information and amendments to the product information can be found on the EMA website.
Acitretin New
PSUR-outcome
|
17/07/2024
Further information and amendments to the product information can be found on the EMA website.
Diclofenac (topical formulations) New
PSUR-outcome
|
17/07/2024
Further information and amendments to the product information can be found on the EMA website.